Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liquid Carbonic was a pioneering global leader in the production and distribution of industrial and medical gases, most notably carbon dioxide, oxygen, and nitrous oxide. Founded in 1888 by Jacob Baur, the company revolutionized the beverage and healthcare industries by developing commercial-scale gas liquefaction and purification technologies. In the healthcare sector, Liquid Carbonic was a critical supplier of medical-grade gases used for respiratory support, surgical insufflation, and clinical anesthesia. The company operated as the primary subsidiary of CBI Industries until its acquisition by Praxair in 1996 for approximately $2.2 billion. This strategic acquisition allowed Praxair (now Linde) to dominate the global carbon dioxide market and significantly expand its healthcare services division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liquid Carbonic.